The global genomics market is entering a period of rapid expansion as genomic technologies become increasingly integrated into healthcare, pharmaceutical research, biotechnology, and other biological applications. The market was valued at USD 21.8 billion in 2025 and is expected to reach USD 22.6 billion in 2026. By 2033, the market is projected to reach USD 72.5 billion, representing a 18.2% CAGR from 2026 to 2033.

North America accounted for the largest regional share, representing 42.3% of global revenue in 2025. Meanwhile, Asia Pacific is expected to record the fastest CAGR during the 2026–2033 forecast period.

Market expansion is being supported by the increasing use of genomics in precision medicine, clinical diagnostics, drug discovery, genetic disease research, agriculture, and industrial biotechnology. Advances in sequencing, genome editing, bioinformatics, and genomic data analytics are also improving the ability to analyze genetic information and translate it into research and healthcare applications.

Market Snapshot

What Is Driving Genomics Market Growth?

The expansion of the genomics industry is closely linked to the growing use of genetic information in clinical decision-making and biological research. Sequencing technologies, genome editing platforms, bioinformatics tools, and data analytics are enabling researchers and healthcare providers to analyze genetic information with increasing efficiency.

Two application areas are particularly important to market development: the growing clinical use of genomics and the broader adoption of precision medicine.

Download a free sample report or claim your copy of this full market intelligence report

Clinical Applications Are Expanding the Role of Genomics

Genomics is becoming increasingly relevant to clinical diagnostics, oncology, and rare disease management. Next-generation sequencing (NGS) and other molecular testing technologies can support the identification of genetic disorders, inherited conditions, and disease-associated variants. Their integration into diagnostic workflows is contributing to disease-risk assessment, prognosis, and treatment-selection processes.

In oncology, genomic technologies are increasingly applied to tumor profiling, biomarker identification, targeted treatment selection, and disease monitoring. Genomic analysis can help identify clinically relevant mutations and characterize tumor heterogeneity while supporting assessment of potential treatment responses.

The expansion of precision oncology, genomics-focused clinical trials, and pharmaceutical partnerships is creating demand for sequencing platforms, reagents, and bioinformatics solutions.

Genomics is also contributing to the diagnosis of rare diseases. Whole-exome sequencing (WES) and whole-genome sequencing (WGS) can help identify disease-causing variants when conventional diagnostic approaches do not provide conclusive results. Greater clinician awareness, expanded newborn screening programs, and government initiatives supporting rare disease diagnosis are further supporting genomic testing adoption.

Precision Medicine Is Strengthening Demand

The increasing adoption of precision medicine is another important factor shaping the genomics market. Genetic information can help healthcare providers develop treatment strategies based on individual genetic profiles, supporting more personalized approaches to disease management.

Advances in sequencing, bioinformatics, and genomic data analytics are facilitating the integration of genomic information into clinical workflows. These capabilities are being applied across areas including oncology, cardiology, rare diseases, and other therapeutic fields.

Genomics is also becoming increasingly important to pharmaceutical and biotechnology companies. Companies are incorporating genomic information into targeted drug development, companion diagnostics, and patient stratification for clinical trials. Genomic-based patient selection can help researchers identify patient populations that may be more responsive to particular therapies, supporting more targeted clinical development.

Investments in precision medicine programs, supportive regulatory initiatives, and the expansion of genomic diagnostic services are contributing to the market's development. As genomic data becomes more integrated with drug discovery and clinical care, its role in personalized healthcare is expected to expand through the forecast period.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Where Is the Market Concentrated?

North America

North America represented the largest regional market in 2025, accounting for 42.3% of global revenue. The U.S. held the largest country-level market share during the same year.

Asia Pacific

Asia Pacific is projected to record the highest CAGR from 2026 to 2033, indicating strong growth momentum during the forecast period.

Leading Market Segments

The supplied market analysis identifies the following leading segments in 2025:

• Application: Functional genomics — 32.8% market share
• Deliverables: Product — 70.0% market share
• End Use: Pharmaceutical and biotechnology companies — 54.8% market share

These segments highlight the importance of functional genomic analysis, genomic products, and pharmaceutical and biotechnology applications within the broader industry.

Technology Is Expanding Genomics Beyond Sequencing

The genomics ecosystem is evolving through advances in sequencing technologies, genome editing, bioinformatics, and data analytics. These developments are enabling more efficient genetic analysis and broadening the practical applications of genomic information.

The resulting capabilities support applications ranging from personalized healthcare and genetic disease research to engineered biological systems and data-driven research. Continued technological development is therefore closely connected with the expansion of genomics across healthcare and biotechnology.

Genomics Market Forecast, 2026–2033

The market is projected to increase from USD 22.6 billion in 2026 to USD 72.5 billion by 2033, reflecting a 18.2% CAGR during the forecast period.

This growth trajectory reflects increasing adoption across clinical applications, precision medicine, pharmaceutical research, and biotechnology, alongside continuing advances in genomic technologies and analytical capabilities.

Companies Covered

The study profiles key participants in the genomics market, including:

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• BGI Genomics

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.